“…Concerning methodological quality, none of the articles included was classified as strong, five obtained moderate classification [23,25,27,29,30], and eight were poor quality [24,26,[31][32][33][34][35]. Considering the instruments categories, it was verified that: (1) only one study was classified as strong in the selection of bias parameter [23], since the rate of participants exceed the 80%, which may be representative of the target population; (2) the randomized controlled trials or controlled clinical trials were classified as strong study design (n = 5) [27,29,[33][34][35], while other type of design was classified as moderate (n = 8) [23][24][25][26]28,[30][31][32]; (3) seven studies revealed no baseline differences between groups in the confounders' section or accounted for at least 80% of significant confounders [24,25,27,29,30,33,35], whereas the studies performed with only one group were not evaluated at this point (n = 5) [23,26,28,31,32]; (4) only one study blinded the assessors and participants, being classified as strong [27]; (5) all studies presented valid and reliable data collection instruments; and (6) in the withdrawals and dropouts parameter, ...…”